Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori J Wirth

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Cetuximab in Human Papillomavirus-Positive Oropharynx CarcinomaLori J Wirth
The Journal of Clinical Endocrinology and Metabolism|November 22, 2018
Still Perfecting Radioiodine in Thyroid Cancer, After All These YearsLori J Wirth
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Chemoprevention of squamous cell carcinoma of the head and neck: no time to lose momentumLori J Wirth
Clinical Advances in Hematology & Oncology : H&O|July 2, 2024
Management of patients with NTRK fusion-positive thyroid cancerLori J Wirth
Clinical Advances in Hematology & Oncology : H&O|October 3, 2015
Targeted therapy for advanced or metastatic differentiated thyroid carcinomaLori J Wirth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cabozantinib in medullary thyroid carcinoma: time to focus the spotlight on this rare diseaseYariv Houvras, Lori J Wirth
Emerging Topics in Life Sciences|February 2, 2021
Checkpoint cluster: biomarkers of responseSara I Pai, Lori J Wirth
Current Cancer Drug Targets|November 30, 2007
Recent advances in combined modality therapy for locally advanced head and neck cancerLori J Wirth, Marshall R Posner
Thyroid : Official Journal of the American Thyroid Association|May 22, 2025
Management of Adverse Events During Treatment for Advanced Thyroid CancerThomas J Roberts, Lori J Wirth
The New England Journal of Medicine|February 10, 2006
Cetuximab and radiotherapy for head and neck cancerMarshall R Posner, Lori J Wirth
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Cetuximab in Human Papillomavirus-Positive Oropharynx CarcinomaLori J Wirth
The Journal of Clinical Endocrinology and Metabolism|November 22, 2018
Still Perfecting Radioiodine in Thyroid Cancer, After All These YearsLori J Wirth
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Chemoprevention of squamous cell carcinoma of the head and neck: no time to lose momentumLori J Wirth
Clinical Advances in Hematology & Oncology : H&O|July 2, 2024
Management of patients with NTRK fusion-positive thyroid cancerLori J Wirth
Clinical Advances in Hematology & Oncology : H&O|October 3, 2015
Targeted therapy for advanced or metastatic differentiated thyroid carcinomaLori J Wirth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cabozantinib in medullary thyroid carcinoma: time to focus the spotlight on this rare diseaseYariv Houvras, Lori J Wirth
Emerging Topics in Life Sciences|February 2, 2021
Checkpoint cluster: biomarkers of responseSara I Pai, Lori J Wirth
Current Cancer Drug Targets|November 30, 2007
Recent advances in combined modality therapy for locally advanced head and neck cancerLori J Wirth, Marshall R Posner
Thyroid : Official Journal of the American Thyroid Association|May 22, 2025
Management of Adverse Events During Treatment for Advanced Thyroid CancerThomas J Roberts, Lori J Wirth
The New England Journal of Medicine|February 10, 2006
Cetuximab and radiotherapy for head and neck cancerMarshall R Posner, Lori J Wirth
Pageof 16